As of Nov 17
| 0.00 / 0.00%|
The 2 analysts offering 12-month price forecasts for CASI Pharmaceuticals Inc have a median target of 3.00, with a high estimate of 4.00 and a low estimate of 2.00. The median estimate represents a +15.38% increase from the last price of 2.60.
The current consensus among 2 polled investment analysts is to Buy stock in CASI Pharmaceuticals Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.